Wat zijn de openingstijden?

Maandag 09:00 - 17:00 Dinsdag 09:00 - 17:00 Woensdag 09:00 - 17:00 Donderdag 09:00 - 17:00 Vrijdag 09:00 - 17:00

R.E.D. Laboratories Brussels Belgium

Startpagina
België
Asse
R.E.D. Laboratories Brussels Belgium

“Uitvoeren van gespecialiseerd onderzoek en diagnostische testen voor chronische immuunziekten.” R.E.D.

Laboratories – your partner of choice for specialty tests

R.E.D. Laboratories develops and performs specialty tests for chronic immune disorders, intestinal dysfunctions, tick-borne diseases (Lyme disease, tick-borne encephalitis, etc) and multifactorial afflictions such as autism and chronic fatigue syndrome (CFS). We are continuously developing new tests according to the specific needs of healt

h care providers. Our focus is to offer tests that are either rarely or not available elsewhere. We are collaborating with national and international Universities and we are involved in several international groups aiming to advance knowledge in biological markers of autism and CFS. In order to offer the most relevant and useful testing possible, we at R.E.D. Laboratories leverage the collective knowledge of prominent physicians, with whom we maintain close collaborations. By collaborating with us, they can contribute to this scientific knowledge base and promote the development of laboratory diagnostics that will benefit their patients.

24/04/2025

Access the Best of US Specialized Testing with RED Laboratories https://bit.ly/3Ygkrga

02/04/2025

On April 2nd, we observe World Autism Awareness Day, a global initiative dedicated to increasing understanding and acceptance of individuals with Autism Spectrum Disorder (ASD).

This day serves as a reminder of the importance of early detection and research in understanding ASD. One significant advancement in this field is the Folate Receptor Alpha Autoantibody Test (FRAT), which detects the presence of folate receptor alpha autoantibodies (FRAAs).

A recent study published in the Journal of Personalized Medicine has identified a significant link between ASD and FRAAs, which are associated with cerebral folate deficiency—a condition observed in some individuals with autism. The FRAT test is a valuable tool that allows researchers and clinicians to explore potential biological factors related to ASD, helping to expand our knowledge of the condition.

This World Autism Awareness Day, we recognize the importance of scientific progress and encourage continued research efforts to enhance early detection and deepen our understanding of autism. https://bit.ly/4iK0gPQ

31/03/2025

At R.E.D. Laboratories, we remain committed to providing you with the highest quality services and innovative testing solutions. In order to continue meeting our high standards and accommodate rising operational costs, we would like to inform you of an upcoming price increase, effective [April 1st].

Our prices have remained unchanged for several years, but the constant increase in the cost of materials, reagents, and services has forced us to make this adjustment. We have made our best effort to keep the price increase to a minimum while maintaining the quality and reliability you expect from us.

Additionally, we have updated our request forms to enhance clarity and efficiency in processing your orders available on our website.

We appreciate your continued trust and support. Should you have any questions or require further assistance, please do not hesitate to contact us at [info@redlabs.be].

Thank you for your understanding and cooperation.

The R.E.D. Laboratories Team https://bit.ly/4iOzJkD

07/03/2025

We are thrilled to announce that R.E.D. Laboratories will be participating as an exhibitor at the upcoming ILADS European Scientific Conference, scheduled for May 1-3, 2025, in Lisbon, Portugal.

The ILADS (International Lyme and Associated Diseases Society) European Scientific Conference is a premier event dedicated to the appropriate diagnosis and treatment of Lyme and associated diseases. This year's conference will focus on the One Health concept, integrating various medical specialties involved in treating Lyme and tick-borne illnesses.

Conference Highlights:

* European Vector-Borne Illness Fundamentals Course: A half-day program on May 1, introducing the newly-created course.
* Scientific Presentations: Full-day sessions on May 2 and 3, covering various aspects of Lyme and tick-borne illnesses.
* Networking Opportunities: Evening social events with physician leaders from around the globe.
* Exhibition Hall: Showcasing medical services and innovations.

We are also pleased to share that Tanja Mijatovic, PhD, will be presenting on "Neglected Infections and Gastrointestinal Dysregulations in Patients with Active Borrelia Infections," providing valuable insights into this critical yet often overlooked aspect of Lyme disease.

We invite all attendees to visit our booth to learn about our latest advancements in diagnostic tools and research methods for Lyme disease and co-infections. Our team will be on hand to discuss how our innovations can support your practice and improve patient outcomes.

Don't miss this opportunity to engage with leaders in the field and deepen your understanding of Lyme disease. We look forward to seeing you in Lisbon!

For more details about the conference, please visit the official ILADS conference page. https://bit.ly/3XALWR9

03/03/2025

The article "Lyme Disease as a Potential Precursor to Anti-N-Methyl-D-Aspartate Receptor Encephalitis: A Case Report" presents a case of a 74-year-old man who developed anti-NMDA receptor encephalitis following Lyme disease. Initially, the patient experienced back pain, myalgia, and memory impairment, which progressed to confusion, behavioral changes, and speech difficulties. Laboratory tests confirmed Borrelia burgdorferi infection, the causative agent of Lyme disease, and subsequent testing revealed the presence of anti-NMDA receptor antibodies in both serum and cerebrospinal fluid. This case suggests that Lyme disease may trigger autoimmune responses resulting in anti-NMDA receptor encephalitis, highlighting the importance of considering this potential complication in patients with neuroborreliosis.

This case further emphasizes the need for early consideration of Lyme disease in the differential diagnosis to avoid prolonged and costly hospitalizations. Finally, late diagnosis and treatment of Lyme disease can result in additional autoimmune complications, including myocarditis and thyroiditis. https://bit.ly/4igA0wt

27/11/2024

Research highlights that Lyme disease during pregnancy can affect a child's neurodevelopment. The disease may be transmitted from mother to fetus, potentially causing developmental delays. Understanding how it impacts pregnancy and child development is crucial for creating effective management strategies and providing support for affected families.

20/10/2024

R.E.D. Laboratories has partnered with IGeneX to offer advanced diagnostic testing for Lyme disease and other tick-borne illnesses in Europe, Africa, and the Middle East. This collaboration enhances access to IGeneX's specialized tests, empowering healthcare professionals and improving patient outcomes in these regions.

19/10/2024

Introducing the MitoSwab™ test—a non-invasive cheek swab that evaluates mitochondrial health by analyzing key enzyme activities. Ideal for those with suspected mitochondrial disorders, it provides insights comparable to traditional muscle biopsies without the invasiveness. A simple, reliable alternative for assessing respiratory chain enzyme dysfunction.

11/10/2024

A recent case report unveils the successful use of phage-based PCR to diagnose and treat Borrelia miyamotoi disease, aiding a patient with joint pain and cognitive issues post-tick bites, where standard tests failed. This technique offers a new avenue for tackling similar tick-borne diseases.

10/10/2024

The 2024 ILADS Scientific Conference is set to redefine Lyme Disease with a focus on blending science and clinical practice. Expect insights on new diagnostic tools and treatment advances for vector-borne illnesses. Engage with experts and explore key developments in this vital medical field.

06/09/2024

The European Conference on Lyme Disease and Crypto-Infections is set for 4-5 October 2024 in France. An exclusive event for health professionals to delve into medical and sector-specific risks. Open online to all interested.

19/08/2024

Join the MAPS 2024 conference from Sept. 5th-7th to explore the latest in functional and translational medicine for conditions like ASD and ADHD. Engage with experts on groundbreaking research and technologies for better care in special needs pediatrics.

Adres

Z.1 Researchpark 100
Asse
1731

Openingstijden

Maandag	09:00 - 17:00
Dinsdag	09:00 - 17:00
Woensdag	09:00 - 17:00
Donderdag	09:00 - 17:00
Vrijdag	09:00 - 17:00

Website

http://www.redlabs.be/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer R.E.D. Laboratories Brussels Belgium nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar R.E.D. Laboratories Brussels Belgium:

Snelkoppelingen

R.E.D. Laboratories – your partner of choice for specialty tests

R.E.D. Laboratories develops and performs specialty tests for chronic immune disorders, intestinal dysfunctions, tick-borne diseases (Lyme disease, tick-borne encephalitis, etc) and multifactorial afflictions such as autism and chronic fatigue syndrome (CFS). We are continuously developing new tests according to the specific needs of health care providers. Our focus is to offer tests that are either rarely or not available elsewhere. We are collaborating with national and international Universities and we are involved in several international groups aiming to advance knowledge in biological markers of autism and CFS.

In order to offer the most relevant and useful testing possible, we at R.E.D. Laboratories leverage the collective knowledge of prominent physicians, with whom we maintain close collaborations. By collaborating with us, they can contribute to this scientific knowledge base and promote the development of laboratory diagnostics that will benefit their patients.